Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L

Jörg Stypmann1, Kerstin Gläser, Wera Roth

  • 1Medizinische Klinik und Poliklinik C (Kardiologie und Angiologie), Universitätsklinikum Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany.

Insights

Cathepsin L deficiency in mice causes dilated cardiomyopathy, leading to enlarged heart chambers, impaired function, and arrhythmias. This highlights the critical role of cathepsin L in maintaining cardiac health.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Dilated cardiomyopathy (DCM) is a major cause of heart failure with high mortality.
  • Myocardial remodeling drives DCM progression, but intracellular proteolysis's role is understudied.
  • Lysosomal cysteine proteases are crucial for cellular homeostasis.

Purpose of the Study:

  • To investigate the role of lysosomal cysteine peptidase cathepsin L (CTSL) in cardiac morphology and function.
  • To elucidate the impact of CTSL deficiency on myocardial remodeling and heart failure development.

Main Methods:

  • Utilized CTSL-deficient (knockout) mice model.
  • Performed echocardiography for cardiac function assessment.
  • Conducted histological and electron microscopy analyses of cardiac tissue.

Main Results:

  • CTSL-deficient mice exhibited significant ventricular and atrial enlargement.
  • Histology revealed interstitial fibrosis, pleomorphic nuclei, and lysosomal abnormalities in cardiomyocytes.
  • Echocardiography showed severely impaired left ventricular function and signs of hypertrophy.
  • Cardiac valve insufficiencies and abnormal heart rhythms (tachycardia, extrasystoles, AV block) were observed.

Conclusions:

  • CTSL is essential for maintaining normal cardiac morphology and function.
  • CTSL deficiency leads to DCM-like phenotype, characterized by structural and functional cardiac deficits.
  • Targeting CTSL may offer therapeutic potential for managing dilated cardiomyopathy.